Cadrenal Therapeutics (CVKD) Stock Chart & Stock Price History → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free CVKD Stock Alerts $0.49 +0.01 (+2.08%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Cadrenal Therapeutics Stock Price Performance5 Day Performance+0.04%1 Month Performance-3.78%3 Month Performance-46.08%6 Month Performance+5.53%Year-To-Date Performance-33.68%1 Year Performance-65.44% Receive CVKD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceThe new financial threat that could wipe out millions…During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.Pay close attention to this important video CVKD Stock Chart for Wednesday, May, 8, 2024 CVKD Chart by TradingView Cadrenal Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$0.48$0.49+2.23%$0.52$0.4855,423 shs$7.86 million05/07/2024$0.50$0.48-4.00%$0.51$0.47144,630 shs$7.69 million05/06/2024$0.49$0.50+1.94%$0.52$0.48158,187 shs$8.01 million05/03/2024$0.47$0.49+5.48%$0.52$0.47439,537 shs$7.85 million05/02/2024$0.45$0.47+2.31%$0.47$0.4476,577 shs$7.44 million05/01/2024$0.44$0.45+3.30%$0.46$0.4367,624 shs$7.28 million Get the Latest News and Ratings for CVKD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$0.45$0.44-2.46%$0.46$0.4343,547 shs$7.04 million04/29/2024$0.43$0.45+4.79%$0.47$0.42197,781 shs$7.22 million04/26/2024$0.42$0.43+1.63%$0.43$0.4281,232 shs$6.89 million04/25/2024$0.43$0.42-1.12%$0.43$0.4154,777 shs$6.78 million04/24/2024$0.43$0.43+0.45%$0.44$0.4238,440 shs$6.86 million04/23/2024$0.41$0.43+4.71%$0.44$0.40108,224 shs$6.83 million04/22/2024$0.40$0.41+1.42%$0.44$0.4063,747 shs$6.52 million04/19/2024$0.43$0.40-6.56%$0.42$0.4067,059 shs$6.43 million04/18/2024$0.42$0.43+1.92%$0.43$0.40162,064 shs$6.88 million04/17/2024$0.39$0.42+8.16%$0.43$0.38169,324 shs$6.75 million04/16/2024$0.41$0.39-3.73%$0.41$0.38154,705 shs$6.24 million04/15/2024$0.41$0.41-1.87%$0.42$0.40144,077 shs$6.48 million04/12/2024$0.44$0.41-5.34%$0.45$0.40156,375 shs$6.61 million04/11/2024$0.44$0.44-1.42%$0.46$0.39349,624 shs$6.98 million04/10/2024$0.41$0.44+8.22%$0.47$0.361.25 million shs$7.08 million04/09/2024$0.51$0.41-19.86%$0.58$0.386.07 million shs$6.54 million04/08/2024$0.56$0.51-8.77%$0.57$0.50362,602 shs$8.17 million04/05/2024$0.61$0.56-8.07%$0.61$0.52123,732 shs$8.95 million04/04/2024$0.60$0.61+1.69%$0.62$0.5819,156 shs$9.73 million04/03/2024$0.62$0.60-3.39%$0.62$0.5864,114 shs$9.57 million04/02/2024$0.62$0.62$0.62$0.6036,625 shs$9.91 million04/01/2024$0.61$0.62+1.48%$0.64$0.6019,830 shs$9.91 million03/29/2024$0.61$0.61$0.64$0.6053,356 shs$9.77 million03/28/2024$0.64$0.61-4.69%$0.64$0.6052,893 shs$9.77 million03/27/2024$0.65$0.64-1.33%$0.64$0.6146,380 shs$10.25 million03/26/2024$0.63$0.65+2.95%$0.65$0.6131,809 shs$10.38 million03/25/2024$0.65$0.63-3.08%$0.65$0.6163,480 shs$10.09 million03/22/2024$0.63$0.65+3.17%$0.65$0.6252,215 shs$10.41 million03/21/2024$0.60$0.63+5.00%$0.65$0.6068,967 shs$10.09 million03/20/2024$0.57$0.60+5.26%$0.60$0.5722,300 shs$9.61 million03/19/2024$0.56$0.57+1.79%$0.60$0.5637,442 shs$9.13 million03/18/2024$0.59$0.56-4.76%$0.61$0.5642,428 shs$8.97 million03/15/2024$0.59$0.59-1.14%$0.61$0.5428,328 shs$9.41 million03/14/2024$0.59$0.59+1.50%$0.62$0.5682,334 shs$7.74 million“Crash Insurance” For Your Retirement (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free.03/13/2024$0.58$0.59+1.21%$0.62$0.5472,976 shs$7.63 million03/12/2024$0.65$0.58-11.03%$0.65$0.52207,744 shs$7.54 million03/11/2024$0.67$0.65-2.81%$0.68$0.5893,662 shs$8.47 million03/08/2024$0.64$0.67+3.86%$0.70$0.6276,764 shs$8.72 million03/07/2024$0.63$0.64+1.66%$0.69$0.6150,525 shs$8.39 million03/06/2024$0.65$0.63-2.16%$0.70$0.6281,234 shs$8.26 million03/05/2024$0.67$0.65-2.53%$0.68$0.62120,689 shs$8.44 million03/04/2024$0.69$0.67-3.96%$0.70$0.6496,246 shs$8.66 million03/01/2024$0.70$0.69-1.65%$0.75$0.6895,638 shs$9.02 million02/29/2024$0.67$0.70+4.45%$0.76$0.67265,159 shs$9.17 million02/28/2024$0.60$0.67+11.96%$0.71$0.60252,254 shs$8.78 million02/27/2024$0.63$0.60-4.79%$0.66$0.59109,696 shs$7.84 million02/26/2024$0.63$0.63+0.37%$0.71$0.61161,371 shs$8.23 million02/23/2024$0.73$0.63-14.05%$0.73$0.60420,585 shs$8.20 million02/22/2024$0.74$0.73-0.68%$0.74$0.69137,654 shs$9.54 million02/21/2024$0.73$0.74+0.90%$0.79$0.6998,060 shs$9.61 million02/20/2024$0.80$0.73-8.58%$0.80$0.69322,520 shs$9.53 million02/19/2024$0.80$0.80$0.90$0.77156,700 shs$10.42 million02/16/2024$0.78$0.80+2.55%$0.90$0.77156,717 shs$10.42 million02/15/2024$0.88$0.78-11.05%$0.86$0.71289,543 shs$10.16 million02/14/2024$0.97$0.88-9.52%$1.01$0.86157,958 shs$11.42 million02/13/2024$1.04$0.97-6.80%$1.02$0.91193,692 shs$12.62 million02/12/2024$1.02$1.04+1.96%$1.05$0.96210,320 shs$13.54 million02/09/2024$0.91$1.02+12.09%$1.15$0.86677,428 shs$13.28 million02/08/2024$1.13$0.91-19.47%$0.99$0.721.71 million shs$11.85 million02/07/2024$1.34$1.13-15.67%$1.34$1.09390,732 shs$14.71 million Related Companies: VIRI Stock Chart TRVN Stock Chart NCNA Stock Chart BFRI Stock Chart BNOX Stock Chart CYCN Stock Chart VCNX Stock Chart EFTR Stock Chart HEPA Stock Chart UPC Stock Chart Receive CVKD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CVKD) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.